相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast Cancer
Theresa A. DiMeo et al.
CANCER RESEARCH (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+cohort in EGF103009, a phase II study
Bella Kaufman et al.
LANCET ONCOLOGY (2009)
Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer
Deborah Silvera et al.
NATURE CELL BIOLOGY (2009)
Molecular targets for treatment of inflammatory breast cancer
Hideko Yamauchi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies
Monica M. Mita et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis
S. Van Laere et al.
BRITISH JOURNAL OF CANCER (2007)
ON TESTING THE SIGNIFICANCE OF SETS OF GENES
Bradley Efron et al.
ANNALS OF APPLIED STATISTICS (2007)
Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer
Steven A. Limentani et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Molecular definition of breast tumor heterogeneity
Michail Shipitsin et al.
CANCER CELL (2007)
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression pro-filing study
Yun Gong et al.
LANCET ONCOLOGY (2007)
Extensions to gene set enrichment
Zhen Jiang et al.
BIOINFORMATICS (2007)
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
Kenneth R. Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Molecular heterogeneity of inflammatory breast cancer: A hyperproliferative phenotype
Dang M. Nguyen et al.
CLINICAL CANCER RESEARCH (2006)
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
Rita Nahta et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer
J Hurley et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis
S Van Laere et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation
I Beuvink et al.
CELL (2005)
Gene expression profiling identifies molecular subtypes of inflammatory breast cancer
F Bertucci et al.
CANCER RESEARCH (2005)
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma
MB Atkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Complement function in mAb-mediated cancer immunotherapy
KA Gelderman et al.
TRENDS IN IMMUNOLOGY (2004)
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy
F Bertucci et al.
CANCER RESEARCH (2004)
Molecular profiling of inflammatory breast cancer:: Identification of a poor-prognosis gene expression signature
I Bièche et al.
CLINICAL CANCER RESEARCH (2004)
Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells
TL Drell et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Update on the management of inflammatory breast cancer
M Cristofanilli et al.
ONCOLOGIST (2003)
Revision of the American Joint Committee on Cancer staging system for breast cancer
SE Singletary et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)